◦
4-H), 3.01 (dd, J = 9.3, 4.0, 1H, 6-H), 3.10 (ddd, J = 10.3, 4.3,
4.0, 1H, 7-H), 3.41 (d, J = 15.9, 1H, 2-H), 3.51 (d, J = 15.9, 1H,
2-H), 3.73 (ddd, J = 9.3, 4.4, 3.2, 1H, 5-H), 4.03 (dd, J = 11.2,
6.5, 1H, 6ꢀ-H), 4.07 (dd, J = 11.2, 6.5, 1H, 6ꢀ-H), 4.45 (ddd, J =
6.5, 6.5, 1.0, 1H, 5-H), 5.07 (ddq, J = 11.4, 6.3, 0.9, 1H, 9-H), 5.32
(ddd, J = 8.6, 4.8, 3.1, 1H, 3ꢀ-H), 5.34 (d, J = 3.5, 1H, 4ꢀ-H), 5.40
(bd, J = 3.0, 1H, 1ꢀ-H) ppm. 13C NMR (100 MHz, CDCl3) d 20.7,
20.7, 20.8, 20.9, 30.3, 36.5, 47.4, 51.8, 54.2, 58.6, 62.4, 66.1, 66.5,
66.8, 69.1, 72.2, 95.0, 165.4, 170.0, 170.3, 170.4, 200.4 ppm.
The 1H NMR data for the anomeric proton of b-11: d 4.92 (dd,
J = 9.5, 2.5, 1ꢀ-H).
15 hours at −78 C, followed by basic work-up (120 mg, A-21),
and iodophenylsulfonate scavenging (200 mg azide resin, 2 mL
CH3CN, microwave irradiation) gave 33.3 mg of 15 (76% yield;
a–b-mixture = 4.7 : 1, determined by NMR on crude product).
Purification by column chromatography led to substantial loss of
material. However, pure samples of both anomers were obtained
ꢀ
by semi-preparative HPLC purification: 7.3 mg of a -15; 19%
yield and 2.4 mg of bꢀ-15; 6% yield. HRMS calcd for C34H38O12Na
[M + Na] 661.2261, observed 661.2270.
aꢀ-15. 1H NMR (400 MHz, CDCl3) d 1.27 (d, J = 6.2, 3H),
1.28 (d, J = 6.4, 3H), 1.89–1.99 (m, 3H), 2.15 (s, 3H), 2.17 (s, 3H),
2.37 (ddd, J = 12.8, 5.1, 1.1, 1H), 2.56 (dd, J = 14.2, 2.3, 1H),
2.73 (dd, J = 14.2, 6.9, 1H), 4.03 (dq, J = 9.7, 6.2, 1H), 4.17 (ddd,
J = 9.4, 8.4, 6.1, 1H), 4.95 (bd, J = 2.8, 1H), 5.03 (ddd, J = 6.9,
4.9, 2.3, 1H), 5.20 (dd, J = 9.7, 9.4, 1H), 5.21 (m, 1H), 5.37 (ddd,
J = 4.9, 3.3, 1.4, 1H), 5.61 (ddd, J = 11.6, 9.5, 5.1, 1H), 5.65 (ddd,
J = 16.0, 9.5, 1.4, 1H), 5.87 (dd, J = 16.0, 3.3, 1H), 7.33–7.41 (m,
4H), 7.46–7.54 (m, 2H), 7.90–8.00 (m, 4H) ppm.
3ꢀ,4ꢀ,6ꢀ -Tri-O-acetyl-a/b-D-galactosyl-(1ꢀ→3)-4,7-di-O-(tert-
butyldimethylsilyl)-decarestrictine D (12). General procedure
with thioglycoside
9 (23 mg, 0.05 mmol), 4,7-di-O-TBS-
decarestrictine D (8) (23 mg, 1 eq.) in CH2Cl2–CH3NO2
˚
(2 + 0.5 mL) with MS 4 A (50 mg) and oxidizing reagent (prepared
from 4 (30 mg, 1.6 eq.) and Tf2O (5.5 lL, 0.8 eq.) in 0.5 mL CH2Cl2)
◦
for 13 hours at −78 C, followed by basic work-up (200 mg, A-
21), and iodophenylsulfonate scavenging (200 mg azide resin, 2 mL
CH3CN, microwave irradiation) gave 16.0 mg of 12 (a–b-mixture:
1 : 0.6; 41% yield) as a colourless oil after column chromatography
(petroleum ether–AcOEt = 20 : 1). Unreacted decarestrictine D
8 was also recovered (28%) after purification. HRMS calcd for
C34H59O12Si2 [M − H] 715.3545, observed 715.3539, calcd for
C34H60O12NaSi2 [M + Na] 739.3521, observed 739.3518.
bꢀ-15. 1H NMR (400 MHz, CDCl3) d 1.24 (d, J = 6.4, 3H),
1.26 (d, J = 6.2, 3H), 1.89 (ddd, J = 12.3, 11.8, 9.9, 1H), 1.81–1.97
(m, 2H), 2.13 (s, 3H), 2.15 (s, 3H), 2.50 (ddd, J = 12.3, 5.1, 2.0,
1H), 2.59 (dd, J = 14.2, 2.8, 1H), 2.68 (dd, J = 14.2, 7.3, 1H), 3.62
(dq, J = 9.5, 6.2, 1H), 4.17 (ddd, J = 10.1, 9.6, 3.7, 1H), 4.69 (dd,
J = 9.9, 2.0, 1H), 5.05 (ddd, J = 7.3, 5.2, 2.8, 1H), 5.15 (ddq, J =
10.7, 6.4, 2.2, 1H), 5.17 (dd, J = 9.5, 9.5, 1H), 5.28 (ddd, J = 11.8,
9.5, 5.1, 1H), 5.35 (ddd, J = 5.2, 3.5, 1.3, 1H), 5.77 (dd, J = 16.0,
3.5, 1H), 5.90 (ddd, J = 16.0, 9.5, 1.3, 1H), 7.33–7.40 (m, 4H),
7.47–7.54 (m, 2H), 7.90–7.95 (m, 4H) ppm.
a-12. 1H NMR (400 MHz, CDCl3) d 0.00–0.12 (m, 12H,
t
t
SiMe2 Bu), 0.85–0.97 (m, 18H, SiMe2 Bu), 1.21 (d, J = 5.5, 3H,
10-H), 1.65–1.87 (m, 2H, 8-H), 2.02 (s, 3H, OAc), 2.06 (s, 3H,
OAc), 2.11–2.17 (m, 2H, 2ꢀ-H), 2.17 (s, 3H, OAc), 2.49 (dd, J =
14.0, 6.0, 1H, 2ax-H), 2.58 (dd, J = 14.0, 1.3, 1H, 2eq-H), 3.94 (ddd,
J = 6.0, 4.1, 1.3, 1H, 3-H), 4.00–4.21 (m, 4H, 6ꢀ-H + 5ꢀ-H + 7-H),
4.32 (ddd, J = 4.1, 2.2, 1.9, 1H, 4-H), 4.92–4.99 (m, 1H, 9-H),
5.31–5.37 (m, 2H, 4ꢀ-H + 3ꢀ-H), 5.40 (bd, J = 2.8, 1H, 1ꢀ-H), 5.58
(dd, J = 15.7, 2.2, 1H, 5-H), 5.88 (ddd, J = 15.7, 9.5, 1.9, 1H, 6-H)
ppm. 13C NMR (100 MHz, CDCl3) d −5.2, −5.0, −4.7, −4.2, 18.1,
18.2, 20.8, 20.8, 20.9, 21.4, 25.8, 25.8, 29.4, 29.6, 44.1, 62.7, 66.2,
66.6, 67.1, 68.0, 71.4, 73.3, 75.7, 93.7, 126.2, 136.5, 170.3, 170.4,
170.4, 170.5 ppm.
(3ꢀꢀ,4ꢀꢀ-Di-O-benzoyl-aꢀꢀ-D-digitoxyl)-(1ꢀꢀ→4ꢀ)-(aꢀ/bꢀ-D-oleandro-
syl)-(1ꢀ→7)-3,4-di-O-acetyl decarestrictine
D (17). General
procedure with disaccharide 16 (40 mg, 0.06 mmol), 3,4-di-
OAc-decarestrictine D (14) (18 mg, 1 eq.) in CH2Cl2–CH3NO2
˚
(2 + 0.5 mL) with MS 4 A (50 mg) and oxidizing reagent
(prepared from 4 (30 mg, 1.4 eq.) and Tf2O (7.1 lL, 0.7 eq.)
in 0.5 mL CH2Cl2), for 15 hours at −78 ◦C, followed by basic
work-up (120 mg, A-21), and iodophenylsulfonate scavenging
(200 mg azide resin, 2 mL CH3CN, microwave irradiation) gave,
ꢀ
after purification, 15.7 mg of a -17 (33% yield), 12.9 mg of
b-12. 1H NMR (400 MHz, CDCl3) d 0.00–0.12 (m, 12H,
bꢀ-17 (28% yield) and 4.1 mg of a fraction of a–b-anomers (1 :
1; 9% yield). The overall yield of the reaction is 70% and the
a–b-selectivity is 1.15 : 1. HRMS calcd C41H50O15Na [M + Na]
805.3047, observed 805.3053, calcd C41H49O15 [M − H] 781.3071,
observed 781.3076.
t
t
SiMe2 Bu), 0.85–0.97 (m, 18H, SiMe2 Bu), 1.22 (d, J = 6.14, 3H,
10-H), 1.65–1.87 (m, 2H, 8-H), 1.93–2.07 (m, 2H, 2ꢀ-H), 2.03 (s,
3H, OAc), 2.06 (s, 3H, OAc), 2.16 (s, 3H, OAc), 2.35 (dd, J = 14.3,
9.8, 1H, 2ax-H), 2.83 (dd, J = 14.3, 3.6, 1H, 2eq-H), 3.81 (dt, J =
6.7, 1.0, 1H, 5ꢀ-H), 3.87 (ddd, J = 9.8, 6.5, 3.6, 1H, 3-H), 4.00–
4.21 (m, 4H, 4-H + 7-H + 6ꢀ-H), 4.80 (dd, J = 9.3, 3.4, 1H, 1ꢀ-H),
4.93–4.99 (m, 1H, 3ꢀ-H), 5.21 (ddq, J = 6.3, 6.3, 1.7, 1H, 9-H),
5.24 (bd, J = 3.0, 1H, 4ꢀ-H), 5.61 (dd, J = 16.0, 4.1, 1H, 5-H),
5.85 (ddd, J = 16.0, 9.2, 1.0, 1H, 6-H) ppm. 13C NMR (100 MHz,
CDCl3) d −4.9, −4.8, −4.6, −4.4, 18.1, 18.1, 20.7, 20.8, 20.8, 21.6,
25.7, 25.8, 31.8, 38.2, 43.5, 61.8, 65.3, 67.9, 68.5, 70.9, 72.1, 73.5,
82.6, 101.1, 126.1, 138.6, 170.0, 170.4, 170.4, 170.5 ppm.
aꢀ-17. 1H NMR (400 MHz, CDCl3) d 1.24 (d, J = 6.5, 3H),
1.26 (d, J = 6.5, 3H), 1.32 (d, J = 6.2, 3H), 1.50 (ddd, J = 12.9,
11.4, 3.5, 1H), 1.71 (ddd, J = 14.2, 11.1, 11.0, 1H), 1.89 (ddd, J =
14.2, 3.3, 1.5, 1H), 2.07 (s, 3H), 2.10–2.25 (m, 2H), 2.37 (s, 3H),
2.37 (ddd, J = 15.0, 3.7, 1.3, 1H), 2.60 (dd, J = 14.1, 3.3, 1H),
2.66 (dd, J = 14.1, 7.5, 1H), 3.24 (dd, J = 9.1, 8.9, 1H), 3.27 (s,
3H), 3.44 (ddd, J = 11.4, 8.9, 5.0, 1H), 3.63 (dq, J = 9.1, 6.2,
1H), 4.04 (ddd, J = 11.0, 9.2, 3.3, 1H), 4.59 (dq, J = 9.5, 6.5,
1H), 4.93 (bd, J = 3.5, 1H), 5.02 (dd, J = 9.5, 3.3, 1H), 5.12 (m,
2H), 5.35 (bdd, J = 4.5, 1.3, 1H), 5.38 (ddd, J = 6.0 3.6, 1.0, 1H),
5.65 (ddd, J = 3.7, 3.5, 3.3, 1H), 5.73 (dd, J = 16.0, 3.6, 1H), 5.87
(ddd, J = 16.0, 9.2, 1.0, 1H), 7.37 (m, 2H), 7.45 (m, 2H), 7.53 (m,
1H), 7.62 (m, 1H), 7.93 (m, 2H), 8.06 (m, 2H) ppm. 13C NMR
(100 MHz, CDCl3) d 17.5, 18.0, 20.9, 21.0, 21.5, 33.8, 34.1, 34.7,
(3ꢀ,4ꢀ-Di-O-benzoyl-2-deoxy-a-L-arabino-hexopyranosyl)-(1ꢀ→7)-
3,4-di-O-acetyl-decarestrictine D (15). General procedure with
thioglycoside 13 (32 mg, 0.06 mmol), 3,4-di-OAc-decarestrictine
D (18.4 mg, 1 eq.) in CH2Cl2–CH3NO2 (2 + 0.5 mL) with MS
˚
4 A (50 mg) and oxidizing reagent (prepared from 4 (33 mg,
1.5 eq.) and Tf2O (7.7 lL, 13 mg, 0.75 eq.) in 0.5 mL CH2Cl2), for
This journal is
The Royal Society of Chemistry 2008
Org. Biomol. Chem., 2008, 6, 893–898 | 897
©